Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Xiangyu Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0000-1607-5873; OpenAlex author ID A5101841406. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. PSMD14 Transcriptionally Activated by MEF2A Promotes Pancreatic Cancer Development by Upregulating SPON2 Expression. Last author DOI 10.1002/kjm2.70007↗
  2. Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.31083/j.fbl2901045↗
  3. Exosomal miRNAs in the microenvironment of pancreatic cancer. Last author DOI 10.1016/j.cca.2023.117360↗
  4. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Last author DOI 10.3389/fimmu.2023.1222719↗
  5. The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in Pancreatic Cancer Cells Last author DOI 10.21203/rs.3.rs-1374979/v1↗
  6. Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity in vitro and in vivo through targeting the NF-κB signaling pathwa… First author DOI 10.18632/aging.103327↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chengru Yang · 2 shared papers, 2024–2025 · strength 0.58
  2. Jianjun Gao · 3 shared papers, 2022–2023 · strength 0.57
  3. Yunfu Cui · 3 shared papers, 2020–2023 · strength 0.51
  4. Xinlei Zou · 2 shared papers, 2023 · strength 0.40
  5. Yunhe Hao · 1 shared paper, 2025 · strength 0.37
  6. Yi Xu · 2 shared papers, 2020–2023 · strength 0.29
  7. Haolin Bao · 1 shared paper, 2024 · strength 0.22
  8. Xingming Jiang · 1 shared paper, 2024 · strength 0.22
  9. Wenjing Sun · 1 shared paper, 2022 · strength 0.17
  10. Dongsheng Wang · 1 shared paper, 2022 · strength 0.17
  11. Hao Wang · 1 shared paper, 2022 · strength 0.17
  12. Pengcheng Kang · 1 shared paper, 2020 · strength 0.11
  13. Daolin Ji · 1 shared paper, 2020 · strength 0.11
  14. Wangyang Zheng · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.